Integra LifeSciences Holdings (IART)

Quick ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash US$ in thousands 246,375 215,157 215,236 591,906 276,402 273,732 309,192 307,367 456,661 511,937 447,152 407,092 513,448 470,231 397,414 408,976 470,166 396,279 360,981 357,712
Short-term investments US$ in thousands 27,192 62,441 81,691 71,194 32,694 19,938 20,200 15,659 0 13,111 4,369
Receivables US$ in thousands 272,370 248,298 271,155 241,092 259,327 256,270 258,663 253,995 263,465 248,268 237,361 234,010 231,831 222,232 229,823 223,542 225,532 218,184 179,143 245,546
Total current liabilities US$ in thousands 922,126 912,563 328,316 302,394 306,980 355,712 377,496 282,293 320,906 304,452 295,596 315,833 340,021 332,858 318,756 412,301 401,013 255,146 212,415 246,485
Quick ratio 0.59 0.58 1.73 2.99 1.85 1.55 1.56 2.04 2.24 2.54 2.33 2.03 2.19 2.08 1.97 1.53 1.73 2.41 2.54 2.45

December 31, 2024 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($246,375K + $27,192K + $272,370K) ÷ $922,126K
= 0.59

The quick ratio of Integra LifeSciences Holdings has shown fluctuations over the period ranging from March 31, 2020, to December 31, 2024. The quick ratio, which measures the company's ability to meet its short-term obligations with its most liquid assets, was relatively stable between March 2020 and June 2022, ranging between 1.73 and 2.54.

However, there was a noticeable decrease in the quick ratio from December 31, 2022, to September 30, 2024, with the ratio dropping to as low as 0.58 and 0.59. This significant decline suggests a potential deterioration in the company's liquidity position during this period.

It is important to note that a quick ratio below 1 indicates that a company may struggle to meet its short-term obligations with its liquid assets alone, which could be a cause for concern for creditors and investors. Therefore, the downward trend in the quick ratio towards the end of the period under review may warrant further investigation into the company's liquidity management and financial health.